Hemoptysis caused by bronchial artery‐pulmonary artery fistula complicated with Dieulafoy disease: A case report Authors: Chongqing Lv, Tao Feng, Shishou Wang, Chen Lin Published: 2024 ABSTRACT AbstractBronchial artery‐pulmonary artery fistula (BPF) is a rare vascular malformation of the bronchial arteries, associated with congenital heart disease, pulmonary hypertension, or pulmonary infections. It typically presents in adulthood and has a low incidence. Another rare vascular anomaly, bronchial Dieulafoy disease (BDD), is characterized by an abnormally developed artery within the submucosa of the bronchial tree. This condition is thought to arise from a combination of congenital dysplasia and chronic airway inflammation or injury. Both BPF and BDD are uncommon causes of hemoptysis, and their simultaneous occurrence is exceptionally rare. This report discusses a case of BPF complicated by BDD in a patient who presented with recurrent hemoptysis. The diagnosis was established through bronchial artery angiography, bronchoscopy, and surgical pathology. By examining the clinical features, imaging findings, and diagnostic criteria of these conditions, this case report aims to enhance clinicians' understanding of cryptogenic hemoptysis and provide valuable insights for clinical practice.Keywords: bronchial artery‐pulmonary artery fistula, bronchial Dieulafoy disease, hemoptysis INTRODUCTION Bronchial artery‐pulmonary artery fistula (BPF) is a bronchial artery malformation characterized by an abnormal shunt between the bronchial artery and the pulmonary artery. It often presents with hemoptysis and various cardiopulmonary symptoms. Medical treatment for this condition is generally ineffective. The diagnosis of BPF primarily relies on bronchial artery angiography. Bronchial Dieulafoy's disease (BDD) is a congenital vascular anomaly typically presenting with recurrent massive hemoptysis. Currently, there is no standardized diagnostic criteria for BDD. This report discusses a rare case of massive hemoptysis caused by the coexistence of BPF and BDD, both of which are sources of cryptogenic hemoptysis. CASE REPORT A 17‐year‐old female patient was admitted to the emergency department on April 2, 2023, due to “hemoptysis lasting 3 h.” The patient experienced sudden onset of hemoptysis 3 h prior to admission, with no apparent trigger. Approximately 10 mL of bright red blood was expectorated. The episode was not associated with cough, sputum production, chest tightness, or shortness of breath. The patient attempted to control the bleeding by self‐administering hemostatic medication, but with limited success, prompting her to seek further medical evaluation. The patient had been in good health previously. On admission, the physical examination revealed the following: heart rate of 105 beats per minute, respiratory rate of 30 breaths per minute, blood pressure of 90/59 mmHg, and oxygen saturation level of 90% (with a fraction of inspired oxygen at 29%). The patient was in poor general condition with decreased breath sounds in the right lung and no adventitious lung sounds bilaterally. A chest computed tomography (CT) scan performed on April 2, 2023, revealed patchy areas of high‐density opacities in both lungs, predominantly in the right lung, with indistinct borders (Figure 1). The initial differential diagnosis included hemoptysis of unknown origin, suspected alveolar haemorrhage in the right lower lobe, and possible pulmonary infection. Further diagnostic testing was conducted, including a complete blood count, coagulation profile with D‐dimer, rheumatologic panel, antinuclear antibodies, anti‐glomerular basement membrane antibodies, and pulmonary tumour markers. All results were within normal limits. Two days later, a bronchial artery CTA was performed, which revealed no abnormalities in the right bronchial artery, though the left bronchial artery was not clearly visualized. The patient declined further investigations, including bronchial artery angiography and bronchoscopy. She was treated with piperacillin for the suspected infection and with etamsylate and tranexamic acid for haemostasis. Her condition improved, and she was subsequently discharged. Chest computed tomography showing multiple patchy areas of increased density in both lungs, with indistinct borders, more pronounced in the right lung. On April 8, 2023, the patient experienced a second episode of hemoptysis, approximately 100 mL, similar to the first time. Given the recurrent condition of her hemoptysis, the possibility of a bronchial artery‐venous malformation or submucosal vascular anomaly in the bronchial lumen was considered. Once her condition stabilized, she underwent bronchial artery embolization 3 days later. Intraoperatively, it was observed that an arteriovenous fistula had formed between the distal first intercostal artery and the right subclavian artery. The right bronchial artery was tortuous and dilated, distributing blood to the right lower lobe, where a pulmonary artery fistula was identified at the distal end. Superselective catheterization of the abnormal bronchial artery was performed using a microcatheter, which confirmed the presence of a BPF (Figure 2A). The distal bronchial artery was embolized with microspheres, and the main trunk of the bronchial artery was embolized with coils. Post‐embolization angiography showed no further visualization of the distal bronchial artery (Figure 2B). The intraoperative diagnosis included bronchial artery‐pulmonary artery fistula, hemoptysis, pulmonary infection, and an intercostal artery‐right subclavian artery fistula. After undergoing bronchial artery embolization, the patient experienced no further episodes of hemoptysis and was discharged in stable condition. However, the patient once again declined to undergo bronchoscopy. Bronchial artery angiography. (A) Bronchial artery angiography shows the formation of a BPF in the right lower lung. (B) Embolization of the bronchial artery using microspheres and coils; no further visualization of the distal bronchial artery. One month after discharge, the patient experienced a severe episode of hemoptysis, with approximately 200 mL of blood expectorated, accompanied by respiratory failure and hemorrhagic shock. After immediate admission, the patient underwent tracheal intubation and bedside bronchoscopy, revealing significant haemorrhage in the right main bronchus. The patient received continuous airway blood suction under bronchoscopy, resulting in gradual cessation of bleeding. Vital signs showed a tendency towards stability, leading to successful weaning and extubation. A follow‐up bronchial artery angiogram showed no abnormalities. Given the low likelihood that the latest hemoptysis episode was related to the bronchial artery‐pulmonary artery fistula, further investigation was warranted. On May 30, under local anaesthesia, bronchoscopy was performed again. The examination revealed that the mucosa at the right lower lobe bronchial orifice was raised, with significant vascular congestion, appearing pale purple in colour, and a small amount of fresh blood was noted in the lumen (Figure 3). Considering the rich local blood supply, no biopsy or brushing was performed. Based on the bronchoscopic findings, BDD was suspected as the cause of hemoptysis. Bronchoscopy showing mucosal elevation at the right lower lobe bronchial orifice. On June 12, 2023, the patient underwent a right lower lobectomy via thoracoscopy. Histopathological examination of the resected right lower lobe revealed large, abnormal blood vessels with a small amount of lymphocytic infiltration, and alveolar haemorrhage was observed around the vessels (Figure 4). Following the lobectomy, the patient experienced no further episodes of hemoptysis and was discharged in good condition. Four months of follow‐up via telephone have shown that the patient's condition remains stable. Pathology of the resected right lower lung lobe. (A) Large, abnormally twisted arterial vessels adjacent to the bronchus (H&E, ×100). (B) The arrow indicates an abnormal arterial vessel (H&E, ×100). DISCUSSION BPF is a rare pulmonary vascular malformation characterized by an abnormal connection between the bronchial artery and the pulmonary artery. The primary symptom is unexplained hemoptysis, which may be accompanied by chest tightness, shortness of breath, palpitations, and chest pain. In some cases, it may be asymptomatic and only discovered during routine examinations or in conjunction with other conditions, such as aortic aneurysm, pulmonary tuberculosis, or valvular heart disease. BPF predominantly occurs in the right lung. In its early stages, imaging may reveal no abnormalities. As the disease progresses, hemoptysis can lead to airway obstruction by thrombi, resulting in atelectasis or pneumonia. Bronchial artery CTA may reveal dilated bronchial arteries or abnormal vasculature with unusual blood supply. 1 In this case, BPF was diagnosed through bronchial artery angiography and treated with interventional embolization, which temporarily improved the hemoptysis. However, the condition recurred, and further examination through bronchoscopy and surgical pathology confirmed the presence of concomitant BDD, which was directly linked to the hemoptysis. Dieulafoy disease was first reported by French physician Dieulafoy in 1898, initially described as a ‘simple ulcer’. 2 It refers to acute luminal haemorrhage caused by the rupture of an artery under external factors, or by the spontaneous rupture of an artery due to vascular malformations in the gastrointestinal tract, bile ducts, or bronchi. The supplying artery penetrates the submucosa without tapering into capillaries, maintaining its diameter and protruding into the lumen. In 1995, Sweets et al. 3 first reported BDD, which is now considered one of the main causes of cryptogenic massive hemoptysis. The pathological feature of BDD is the rupture of an abnormally dilated or malformed artery in the bronchial submucosa, leading to bleeding. The clinical presentation of Dieulafoy disease is non‐specific, in this case, the initial symptom was hemoptysis. In young patients, we primarily considered causes like pulmonary tuberculosis, vasculitis, or pulmonary‐renal syndrome, a routine bronchoscopy should have been performed. The patient in this case refused bronchoscopy, delaying the diagnosis. After discharge with conservative hemostatic treatment, the patient continued to experience recurrent hemoptysis. Subsequent bronchoscopy revealed a raised, markedly congested mucosa at the right lower lobe bronchus, consistent with the bronchoscopic findings of Dieulafoy disease. The diagnosis was ultimately confirmed through pathological examination following right lower lobectomy. Due to its lack of specificity in diagnosing BDD, bronchial artery angiography typically only reveals localized increases or tortuous dilatation of bronchial artery branches, failing to identify the corresponding site observed during bronchoscopy. Consequently, the second hemoptysis episode in this patient did not yield positive results for BDD through bronchial artery angiography. In such cases where confirmation of BDD is not achieved via arteriography, performing bronchoscopy becomes necessary. Endobronchial ultrasound (EBUS) and narrow band imaging (NBI) are valuable tools for endoscopic diagnosis of BDD. NBI can effectively display mucosal vessel morphology and surface structure, aiding in vascular disease diagnosis. EBUS assists in clarifying the nature of endobronchial eminence lesions by demonstrating blood flow and facilitating identification of vascular malformations beneath the mucosal eminence. 4 Respiratory endoscopy also plays a crucial role in both diagnosing and treating BDD as it enables localization of bleeding pulmonary lobes prior to bronchial artery embolization (BAE), thereby assisting with balloon occlusion procedures when massive bleeding occurs. The pathogenesis of bronchopulmonary fistula (BPF) primarily involves abnormal connections between the bronchial artery and pulmonary artery resulting from structural or functional defects during fetal development. As individuals age, blood flow increases, leading to bronchial artery dilation, elevated pressure in the pulmonary vascular bed, and subsequent hemoptysis. 1 Contributing factors to BPF include: (1) congenital bronchial artery hypoplasia; (2) chronic airway inflammation or injury; (3) long‐term smoking history; (4) acquired diseases or normal vascular variations. 5 Although the exact mechanism underlying this co‐occurrence remains unclear, we speculate that it may be attributed to congenital abnormalities of the bronchopulmonary arteries or simply variations in normal vessels. In conclusion, the combination of BPF and BDD is an exceedingly rare condition that often poses challenges for diagnosis solely based on chest CT scans. When a patient presents with recurrent massive hemoptysis of unknown origin, it is crucial to consider abnormal bleeding caused by vascular malformation. If conservative medical treatment fails to address hemoptysis and the bleeding site is located in the right bronchus, Dieulafoy's disease of the bronchus should be highly suspected. Confirming the diagnosis necessitates employing various examination methods such as bronchial arteriography and bronchoscopy. AUTHOR CONTRIBUTIONS Chongqing Lv involved in the conceptualization, data curation, investigation, and project administration of the study. Tao Feng contributed to the conceptualization, data curation, and investigation. Both Chongqing Lv and Tao Feng contributed equally as co‐first authors. Shishou Wang was responsible for the formal analysis and methodology. Chen Lin involved in conceptualization, data curation, project administration, investigation, and supervision of the entire project. All authors meet the authorship criteria and have approved the final version of the manuscript. CONFLICT OF INTEREST STATEMENT None declared. ETHICS STATEMENT This study was approved by the Ethics Committee of Shengli Oilfield Central Hospital (approval number: YXLL202413401). Patients were consented by an informed consent process that was reviewed by the Ethics Committee of Shengli Oilfield Central Hospital and certify that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki. The authors declare that written informed patient consent for publication was obtained using the form provided by the Journal. Lv C, Feng T, Wang S, Lin C. Hemoptysis caused by bronchial artery‐pulmonary artery fistula complicated with Dieulafoy disease: A case report. Respirology Case Reports. 2024;12(12):e70075. 10.1002/rcr2.70075 Chongqing Lv and Tao Feng have contributed equally as co‐first authors. Associate Editor: Johnny Chan DATA AVAILABILITY STATEMENT The data that support the findings of this study are available from the corresponding author upon reasonable request. REFERENCES Associated Data Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.